
Eli Greenblat
Senior Business Reporter at The Australian
Senior business reporter with The Australian, covering the retail & beverage sectors as well as the economy and stockmarket. Views my own.
Articles
-
3 weeks ago |
stockhead.com.au | Eli Greenblat
A long-delayed copper project in Arizona controlled by Rio Tinto (ASX:RIO) and backed by BHP (ASX:BHP) has been fast-tracked by the Trump White House as the US and China vie for supremacy in the minerals vital to the energy transition and advanced military hardware.
-
3 weeks ago |
stockhead.com.au | Eli Greenblat
Stockhead is providing factual information where there is a reasonable likelihood of doubt. The information is not intended to imply any recommendation or opinion about a financial product. A NOTE ABOUT RELEVANT ADVERTISING We collect information about the content (including ads) you use across this site and use it to make both advertising and content more relevant to you on our network and other sites.
-
2 months ago |
futures.tradingcharts.com | Eli Greenblat
Mar 16, 2025 (The Australian - ABIX via COMTEX) --Internal research by supermarket chain Woolworths has revealed that consumers think that the cost-of-living crisis is getting worse, with shoppers ranking grocery bills ahead of mortgage and rent payments and utilities bills in terms of financial difficulty.
-
2 months ago |
futures.tradingcharts.com | Eli Greenblat
Mar 16, 2025 (The Australian - ABIX via COMTEX) --Internal research by supermarket chain Woolworths has revealed that consumers think that the cost-of-living crisis is getting worse, with shoppers ranking grocery bills ahead of mortgage and rent payments and utilities bills in terms of financial difficulty.
-
May 6, 2024 |
theaustralian.com.au | Eddy Sunarto |David Ross |Eli Greenblat
Lumos Diagnostics (ASX:LDX) has completed the first phase of its development agreement to develop a new foetal fibronectin (fFN) test for leading women’s health company, Hologic (NASDAQ: HOLX). On January 11, Lumos shared some exciting news about teaming with Hologic. They signed two deals: one worth $10 million for intellectual property and another valued at $4.7 million for development.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 4K
- Tweets
- 35K
- DMs Open
- No